Corvus Pharmaceuticals, Inc. — Director's Dealing 2018

Jan 23, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2018-01-19

Reporting Person: Buggy Joseph J (EVP Discovery Research)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.0001 par value	84876	Direct
Common Stock, $0.0001 par value	266310	Indirect

Footnotes

F1: A portion of these shares is subject to a right of repurchase held by the Issuer.

F2: These shares are held by Buggy / Cooper Living Trust dated June 25, 2014, Joseph J. Buggy / Anne Cooper Trustees (the "Buggy Trust"). Dr. Buggy has shared voting, investment and dispositive power over the shares held by the Buggy Trust.